Insider Transactions Reported by 8 Insiders of BioRestorative Therapies, Inc.

Symbol
BRTX on Nasdaq
Location
Melville, NY

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

BioRestorative Therapies, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dale Broadrick 10%+ Owner $1,459,770 28 Oct 2024
Lance Alstodt President, CEO, COB, Director, 10%+ Owner $299,995 06 Oct 2025
Francisco Silva VP of Research and Development, Director $291,568 06 Oct 2025
Robert Eugene Kristal Chief Financial Officer $12,631 14 Feb 2025
David A. Rosa Director 14 Feb 2025
Patrick F. Williams Director 14 Feb 2025
Nickolay Kukekov V Director 14 Feb 2025
Robert Paccasassi VP, QA and Reg Compliance 13 Feb 2024

Recent Insider Transactions by Companies or Individuals for BioRestorative Therapies, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Francisco Silva BRTX Comon Stock Award 7.34% 11,719 171,384 06 Oct 2025 Direct
Francisco Silva BRTX Warrant Award 11,719 11,719 06 Oct 2025 Direct
Lance Alstodt BRTX Common Stock Award 9.09% 15,625 187,497 06 Oct 2025 Direct
Lance Alstodt BRTX Warrant Award 11,719 11,719 06 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.